Name: The COPD pipeline
Creator: Yasser, Mushtaq
Keywords: Inflammation, 0301 basic medicine, Pulmonary Disease, Chronic Obstructive, 0303 health sciences, 03 medical and health sciences, Risk Factors, Drug Design, Anti-Inflammatory Agents, Humans, Bronchodilator Agents

descriptionPublicationkeyboard_double_arrow_right Article 14 Mar 2014 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 13, pages 253-254 (issn: 1474-1776, eissn: 1474-1784,

Authors: Yasser, Mushtaq;

doi: 10.1038/nrd4254

pmid: 24625824

The COPD pipeline

- Summary
- Subjects
- Metrics

Abstract

Therapeutic approaches to treat chronic obstructive pulmonary disease (COPD) are varied and recent approvals have diversified treatment options. Here, Mushtaq discusses the current COPD pipeline and provides a market outlook for newly approved and late-stage drugs.

Keywords

Inflammation, Pulmonary Disease, Chronic Obstructive, Risk Factors, Drug Design, Anti-Inflammatory Agents, Humans, Bronchodilator Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	15
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%